General Information of Drug (ID: DMX1RKJ)

Drug Name
ISIS-SMNRx
Indication
Disease Entry ICD 11 Status REF
Spinal muscular atrophy 8B61 Phase 3 [1]
Cross-matching ID
PubChem CID
131801471
TTD ID
D0M7HZ

References

1 ClinicalTrials.gov (NCT02292537) A Study to Assess the Efficacy and Safety of ISIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy. U.S. National Institutes of Health.